CI_with has_DoseForm has_Ingredient has_MoA has_PE may_prevent may_treat drug associated with AE Coronary Artery Disease [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Gallbladder Diseases [Disease/Finding] Hypercholesterolemia [Disease/Finding] Hyperlipoproteinemias [Disease/Finding] Liver Cirrhosis, Biliary [Disease/Finding] Hypertriglyceridemia [Disease/Finding] Liver Failure [Disease/Finding] Kidney Failure [Disease/Finding] Fenofibrate [Chemical/Ingredient] Decreased Lipolysis [PE] Unknown Cellular or Molecular Interaction [MoA] [CV350] ANTILIPEMIC AGENTS Oral Tablet [Dose Form] FENOFIBRATE FENOFIBRATE,MICRONIZED 48MG TAB [VA Product] VA Product C276961 C1533455 4017375 Fenofibrate 48 MG Oral Tablet FENOFIBRATE,MICRONIZED 48MG TAB 0 <Product_Component>FENOFIBRATE</Product_Component><Strength>48</Strength><Unit>MG</Unit><VA.IEN>3766</VA.IEN> FENOFIBRATE,MICRONIZED 48MG TAB MG <VANDF_Record>50.68^17012^Inactive/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>17012</VA_IEN><VA_Status>Inactive/Master</VA_Status> N0000165030 FENOFIBRATE TAB 非诺贝特微粉颗粒 48 477562 gastrointestinal disorder AE muscle function disorder AE skin allergy AE severe rhabdomyolysis AE FENOFIBRATE,MICRONIZED 48MG TAB [VA Product] FENOFIBRATE,MICRONIZED 48MG TAB VA Product MG <VANDF_Record>50.68^17012^Inactive/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>17012</VA_IEN><VA_Status>Inactive/Master</VA_Status> C276961 C1533455 N0000165030 FENOFIBRATE TAB 4017375 非诺贝特微粉颗粒 Fenofibrate 48 MG Oral Tablet 48 FENOFIBRATE,MICRONIZED 48MG TAB 0 <Product_Component>FENOFIBRATE</Product_Component><Strength>48</Strength><Unit>MG</Unit><VA.IEN>3766</VA.IEN> 477562